Literature DB >> 17164142

The role of cyclooxygenase-2 and prostaglandins in colon cancer.

Annie L Eisinger1, Stephen M Prescott, David A Jones, Diana M Stafforini.   

Abstract

The temporal association between loss of function of the tumor suppressor adenomatous polyposis coli (APC) and overexpression of cyclooxygenase 2 (COX-2) has been demonstrated in vivo and has led to the hypothesis that APC regulates COX-2 expression. This could potentially occur through a variety of mechanisms including the well-characterized ability of APC to negatively regulate Wnt signaling and decrease expression of target genes. However, recent findings suggest that the products of COX-2 elicit effects that occur upstream of the beta-catenin/TCF/LEF pathway. This review will focus on the regulation of COX-2 by APC and the interplay between COX-2 and the Wnt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17164142     DOI: 10.1016/j.prostaglandins.2006.05.026

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  30 in total

1.  COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk.

Authors:  Juliët H Hoff; Rene H M te Morsche; Hennie M J Roelofs; Elise M J van der Logt; Fokko M Nagengast; Wilbert H M Peters
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

2.  Natural products and colon cancer: current status and future prospects.

Authors:  Subapriya Rajamanickam; Rajesh Agarwal
Journal:  Drug Dev Res       Date:  2008-11-01       Impact factor: 4.360

3.  Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial.

Authors:  Myfanwy H Hopkins; Joy Owen; Thomas Ahearn; Veronika Fedirko; W Dana Flanders; Dean P Jones; Roberd M Bostick
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-30

4.  The tumor microenvironment in colorectal carcinogenesis.

Authors:  Vijay G Peddareddigari; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Microenviron       Date:  2010-03-05

5.  Comparison of biomarker expression between proximal and distal colorectal adenomas: The Tennessee-Indiana Adenoma Recurrence Study.

Authors:  Timothy Su; M Kay Washington; Reid M Ness; Douglas K Rex; Walter E Smalley; Thomas M Ulbright; Qiuyin Cai; Wei Zheng; Martha J Shrubsole
Journal:  Mol Carcinog       Date:  2016-08-11       Impact factor: 4.784

6.  Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.

Authors:  Gillian Hawcroft; Paul M Loadman; Andrea Belluzzi; Mark A Hull
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

7.  Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.

Authors:  Subapriya Rajamanickam; Balaiya Velmurugan; Manjinder Kaur; Rana P Singh; Rajesh Agarwal
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

8.  Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways.

Authors:  Cédric Carli; Christine N Metz; Yousef Al-Abed; Paul H Naccache; Ali Akoum
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

9.  The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.

Authors:  Cyril Sobolewski; Claudia Cerella; Mario Dicato; Lina Ghibelli; Marc Diederich
Journal:  Int J Cell Biol       Date:  2010-03-17

10.  Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.

Authors:  O Galamb; S Spisák; F Sipos; K Tóth; N Solymosi; B Wichmann; T Krenács; G Valcz; Z Tulassay; B Molnár
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.